Monoclonal antibodies fight antimicrobial resistance
This is a news story, published by ScienceDaily, that relates primarily to Baker news.
Baker news
For more Baker news, you can click here:
more Baker newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
antimicrobial resistant Acinetobacter baumannii. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest monoclonal antibody drug news, Monoclonal antibodies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
antimicrobial resistanceScienceDaily
•Monoclonal antibodies offer hope for tackling antimicrobial resistance
81% Informative
A. baumannii bacteria can cause life-threatening respiratory illness and sepsis in vulnerable individuals, particularly in newborn babies whose immune systems have not fully developed.
Researchers at the University of Cambridge have developed a monoclonal antibody drug, using a technique involving genetically engineered mice.
The research was funded by the Bill & Melinda Gates Foundation , the UK Medical Research Council Newton Fund , the Viet Nam Ministry of Science and Technology , and Wellcome .
Professor Baker says monoclonal antibodies are safe and that they work, and the technology exists to produce them.
VR Score
89
Informative language
94
Neutral language
75
Article tone
formal
Language
English
Language complexity
77
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links